STRATEGIC SCIENTIFIC ADVISORY · INDUSTRIES SERVED

Industries served.Regulated science, commercial reality.

The sectors below share a common problem: translating credible science into a defensible, commercially viable asset.

SECTORS

Where the work applies.

Early and mid-stage programmes where mechanistic credibility determines financeability.

Repair and renewal approaches requiring careful separation of demonstrated effect from field enthusiasm.

Device-adjacent biology where the claimed mechanism must survive regulatory scrutiny.

A sector where commercial pressure routinely outpaces evidence, and where disciplined substantiation is a competitive advantage.

Programmes built on senescence, cellular stability, and repair biology, assessed against what the data genuinely support.

Skin and follicular biology, including the intracrine and immune mechanisms underlying chronic dermatologic conditions.

Products sold on scientific claims into channels that increasingly audit those claims.

Ingredient-level evaluation where evidence quality varies widely and claim exposure is high.

Founder-led organizations needing senior scientific judgment before the first major capital commitment.

Companies acquiring or in-licensing science developed elsewhere, and needing an independent read on it.

SELECTIVE COLLABORATIONS

Scientific rigour applied to the commercial questions each sector actually faces.